Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03924661 · ClinicalTrials.gov registry record
SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
A clinical trial of Aortic Valve Disease, sponsored by Abbott Medical Devices.
- Active
- Registry status
- 20
- Enrollment target
- 13
- Study locations
NCT03924661 is a study of Aortic Valve Disease that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 20 participants, below the 18,616-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (100% lower). The trial reports 13 study locations across 10 states.
The verdict
NCT03924661, a study of Aortic Valve Disease, is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 13
- Study locations
Study Summary
This PAS is an observational, non-randomized, multi-center, single arm, clinical study to evaluate long term safety and effectiveness of the SJM™ Masters Series Hemodynamic Plus (HP) 15mm aortic mechanical heart valve (15 AHPJ-505) as a replacement device for pediatric patients with a diseased, damaged, or malfunctioning aortic valve.
Conditions Studied
Interventions
- DEVICE Aortic Valve Replacement
Study Locations (13)
California
- Children's Hospital Los Angeles (USC) - Los Angeles
- Valley Children's Hospital - Madera
- Sutter Medical Center, Sacramento - Sacramento
Texas
- Dell Children's Medical Center - Austin
- Children's Medical Center Dallas - Dallas
Florida
- Variety Children's Hospital - Miami
Georgia
- Children's Healthcare of Atlanta - Atlanta
Mississippi
- University of Mississippi Medical Center - Jackson
Ohio
- Cincinnati Children's Hospital - Cincinnati
Baden-Wurttemberg
- Sana - Herzchirurgische Klinik Stuttgart GmbH - Stuttgart
Bavaria
- Deutsches Herzzentrum München des Freistaates Bayern - München
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-10-24 |
| Est. Completion | 2028-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03924661
The ClinicalTrials.gov registry entry for NCT03924661 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 18,616-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (100% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aortic Valve Disease appearing as the primary indexed condition, and to 1 intervention - of which Aortic Valve Replacement is the first listed.
NCT03924661 reports 13 study locations spanning 10 distinct geographic areas - top geographies include California, Texas, Florida.
Frequently Asked Questions
What is clinical trial NCT03924661 about?
NCT03924661 is a clinical study titled "SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy". This PAS is an observational, non-randomized, multi-center, single arm, clinical study to evaluate long term safety and effectiveness of the SJM™ Masters Series Hemodynamic Plus (HP) 15mm aortic mechanical heart valve (15 AHPJ-505) as a replacement device for pediatric patients with a diseased, dama...
What is the current status of trial NCT03924661?
This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2019-10-24. Estimated completion is 2028-10.
What conditions does trial NCT03924661 study?
This clinical trial studies the following conditions: Aortic Valve Disease.
What interventions are being tested in trial NCT03924661?
The interventions under investigation include: Aortic Valve Replacement (DEVICE).
Who is sponsoring clinical trial NCT03924661?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03924661 being conducted?
This trial has 13 study locations across California, Florida, Georgia, Mississippi, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The JenaValve ALIGN-AR LVAD Registry
RECRUITING · NA
-
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
RECRUITING · NA
-
Valved Graft PMCF Study
RECRUITING
-
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
RECRUITING · NA
-
Prospective Long-Term Outcomes of a Standardized Ross Procedure
RECRUITING
-
Avalus Ultra Post-Approval Study (PAS)
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.